Arca
Skip to content
Tools
Tools

Oropharynx cancer

Drug research and approvals for oropharynx cancer: what is recruiting, what Health Canada authorized, FDA orphan designations and EU medicines. See every condition.

As of Nov 22, 2026, 141 studies of oropharynx cancer are recruiting on ClinicalTrials.gov, and Health Canada has authorized 7 drug trials for it since 2013.

  • Recruiting worldwide: 141
  • Trials authorized in Canada: 7
  • FDA orphan approvals: 0
  • EU medicines: 0

Recruiting now

Newest posted first, of 141 recruiting on ClinicalTrials.gov ↗

How its trials ended

333 ClinicalTrials.gov studies of the condition, classified by TrialPanorama, partly automatically, so some labels are wrong

Of the 82 whose ending is known, 22% met their primary endpoint, 6% missed it and 72% stopped early.

  • Ongoing11835%
  • Completed, result not reported11234%
  • Stopped: other or unclear319%
  • Status unknown216%
  • Met its primary endpoint185%
  • Stopped: enrollment or feasibility144%
  • Stopped: sponsor or business decision62%
  • Missed its primary endpoint52%
  • Stopped: funding41%
  • Stopped: lack of efficacy31%
  • Stopped: safety1<1%

Trials authorized in Canada

Newest first; search them all in Canada trials
Aug 3, 2022Spect-ct guided elective contralateral neck treatment (SELECT) for patients with lateralized oropharyngeal cancer: a phase III randomized controlled trialTechnetium tc 99M tsc / Technelite / Ultra-technekowCanadian Cancer Trials Group, Cancer Research Institute, Queen's UniversityOngoing
Aug 5, 2021A randomized phase II/III trial of deintensified radiation therapy for patients with early-stage, P16-positive, non-smoking associated oropharyngeal cancerOpdivoNrg OncologyClosed
Jan 13, 2021A feasibility trial of lymphatic mapping with spect-ct for evaluating contralateral disease in lateralized oropharynx cancer using 99m-technetium sulfur colloidTechnetium tc 99M sulfur colloidUniversity Health NetworkOngoing
Jul 23, 2018Induction chemotherapy followed by transoral robotic surgery and neck dissection for definitive management of oropharyngeal squamous cell carcinomaDocetaxel/ Cisplatin/ CarboplatinMcGill University Health CentreOngoing
Jan 5, 2018Randomized phase II study of cisplatin plus radiotherapy versus durvalumab plus radiotherapy followed by adjuvant durvalumab versus durvalumab plus…Durvalumab / TremelimumabCanadian Cancer Trials Group, Cancer Research Institute, Queen's UniversityClosed
Nov 18, 2014A randomized phase II trial for patients with P16 positive, non-smoking associated, locoregionally advanced oropharyngeal cancerCisplatinNrg OncologyClosed
Oct 31, 2013Randomized phase II trial of transoral endoscopic head and neck surgery followed by risk-based imrt and weekly cisplatin versus imrt and weekly cisplatin for…CisplatinAmerican College of Radiology Radiation Therapy Oncology GroupPending

Condition names come from Health Canada's trial database. Orphan designations and EU medicines are matched when their indication names the condition as whole words, so a broader or differently worded indication can be missed. Recruiting counts are live from ClinicalTrials.gov's own condition search, refreshed daily. ClinicalTrials.gov, Health Canada Clinical Trials Database, FDA orphan designations, EMA

Esc

Type a name: a tool, a company, a drug or brand, a condition, a gene or a state. Identifiers like K231234, NCT05012345 or NDA 215866 open their record.

Logos are each company's own site icon, matched by name through Wikidata, or logos provided by Logo.dev.Company names and logos identify the companies in public FDA and registry records and do not imply endorsement.